Skip to content
2000
Volume 14, Issue 4
  • ISSN: 1567-2018
  • E-ISSN: 1875-5704

Abstract

Background: Glaucoma, a chronic eye condition caused by progressive degeneration of retinal ganglion cells may result in permanent blindness. The restricted efficiency of currently available glaucoma treatments has awakened a global need for designing a novel anti-glaucoma drug delivery mechanism that targets the drug to the site of action in a sustained manner with less toxicity and side effects. With reference to this global problem in the present study, we have fabricated a biodegradable transparent polymeric material loaded with minimum amount of anti-glaucoma drug, acetazolamide. Methods: The drug was modified using a suitable nanocarrier for its sustained drug release. The efficient modification of nanocarrier encapsulated drug as well as the drug loaded polymeric film was studied using various characterization techniques such as UV-visible spectrophotometry, spectroflurimetry, polarizing optical microscope, Fourier transform infrared spectroscopy (FTIR), atomic force microscopy (AFM), X-ray diffraction (XRD), thermogravimetric analysis and differential scanning calorimetry (TGA/DSC). Results: The characterization techniques indicated efficient transformation of the crystalline drug in to amorphous during nanocarrier encapsulation. The in-vitro drug release study in simulated tear fluid (STF) showed prolonged release of the drug from the nano drug complex for 3 h with the complete degradation of the polymer matrix within 5 min. Conclusion: The fabricated biomaterial showed excellent potential to be developed in to a drug loaded contact lens for sustained glaucoma drug delivery with benefits of low drug content and fewer drug induced side effects.

Loading

Article metrics loading...

/content/journals/cdd/10.2174/1567201813666161018153547
2017-06-01
2025-05-20
Loading full text...

Full text loading...

/content/journals/cdd/10.2174/1567201813666161018153547
Loading

  • Article Type:
    Research Article
Keyword(s): Acetazolamide; biodegradable; contact lenses; drug delivery; glaucoma; nanodrugs; β-cyclodextrin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test